Taste steering at home for people having chemotherapy for cancer
Tests taste steering at home to help adults enjoy food during chemotherapy.
Plain-language title generated from the registry record
Registry title: The TASTY-steering Study
Key facts
- Where
- Amsterdam, Arnhem, Dirksland, Ede, Groningen, Nijmegen, Rotterdam, Scheemda, Veldhoven, and Zwolle, NetherlandsSee the 11 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Source: NCT07258563, who can take part
Where in Netherlands
- Amsterdam UMCAmsterdam, NetherlandsTaking people
- Rijnstate ZiekenhuisArnhem, NetherlandsNot yet recruiting
- Van Weel-Bethesda ZiekenhuisDirksland, NetherlandsNot yet recruiting
- Ziekenhuisvoorzieningen Gelderse ValleiEde, NetherlandsTaking people
- Martini ZiekenhuisGroningen, NetherlandsTaking people
- University Medical Center GroningenGroningen, NetherlandsTaking people
- Radboud University Medical CenterNijmegen, NetherlandsNot yet recruiting
- Ikazia ZiekenhuisRotterdam, NetherlandsTaking people
- Ommelander Ziekenhuis GroningenScheemda, NetherlandsTaking people
- Maxima Medisch CentrumVeldhoven, NetherlandsNot yet recruiting
- Isala KliniekenZwolle, NetherlandsNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Medical Center Groningen
- Trial code
- NCT07258563
- Record updated
- 15 July 2026
- Original description
This is a multicentre non-blinded randomised intervention trial with a parallel cluster design. The multicentre study will be performed at 12 hospitals in the Netherlands. A parallel cluster design per hospital was selected to prevent contact between participants in the same hospital who are randomised into different study arms. Such contact may result in bias as it may allow for patients in the control arm to be informed about elements of taste steering.Read full original descriptionShow less
Taste Steering in Patients With Cancer Who Are Treated With Chemotherapy: a Multicentre Randomized Intervention Trial
This is a multicentre non-blinded randomised intervention trial with a parallel cluster design. The multicentre study will be performed at 12 hospitals in the Netherlands. A parallel cluster design per hospital was selected to prevent contact between participants in the same hospital who are randomised into different study arms. Such contact may result in bias as it may allow for patients in the control arm to be informed about elements of taste steering.
To examine the effect of at-home taste steering versus standard care on food enjoyment, the obtained results and outcomes will be measured 1) at baseline before chemotherapy is started, 2) at week 0 when taste or smell alterations occur, and 3) after 6 weeks. The taste steering will take place at home. The control group will receive usual care. Questionnaires will be filled in online at home, while taste and smell tests and saliva collection will be conducted either at home or in the hospital during regular visits. Patients in both study arms are contacted by their dietitian every 3 weeks.
Some hospitals have implemented elements of taste steering. However, these elements are focused on patients who are admitted to the hospital, and therefore only interfere to a limited extent with the present study that is directed at patients managing their taste alterations at home. Experience with the Smaakpupil tool indicates that the algorithm reaches saturation after 3-4 weeks. Therefore, an intervention period of 6 weeks has been selected.
Inclusion: Age ≥18 and ≤70 years; Indication to start chemotherapy for:; Metastatic triple negative breast cancer; Metastatic testicular cancer; Stage II-IV diffuse large B cell lymphoma; Chemotherapy scheduled to start in the next 6 weeks; Consuming solid foods and drinks is possible; ≤50% of recommended daily intake in kcal consists of oral nutritional supplements; Oral mucositis grade ≤2 (Common Terminology Criteria for Adverse Events, version 5.0); Ability to comply with all protocol-required actions; Written informed consent; For the intervention phase only: subjective change in taste since start of chemotherapy.
Exclusion: Previous or current radiotherapy of head and neck region; Chronic (>1 month) high dose corticosteroids (>10 mg prednisone/day or equivalent); Pregnancy; Currently experiencing taste or smell problems; Enteral feeding through tube or parenteral feeding; Participation in another clinical trial aimed at preventing or treating taste and/or smell alterations.